- Home
- NXGL vs TOI Comparison
NXGL vs TOI Comparison
Compare NXGL & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- TOI
- Stock Information
- Founded
- NXGL 1997
- TOI 2007
- Country
- NXGL United States
- TOI United States
- Employees
- NXGL N/A
- TOI N/A
- Industry
- NXGL Medical/Dental Instruments
- TOI Medical/Nursing Services
- Sector
- NXGL Health Care
- TOI Health Care
- Exchange
- NXGL Nasdaq
- TOI Nasdaq
- Market Cap
- NXGL 23.8M
- TOI 22.6M
- IPO Year
- NXGL 2021
- TOI N/A
- Fundamental
- Price
- NXGL $3.28
- TOI $0.70
- Analyst Decision
- NXGL
- TOI Strong Buy
- Analyst Count
- NXGL 0
- TOI 1
- Target Price
- NXGL N/A
- TOI $2.50
- AVG Volume (30 Days)
- NXGL 121.9K
- TOI 957.0K
- Earning Date
- NXGL 11-13-2024
- TOI 11-13-2024
- Dividend Yield
- NXGL N/A
- TOI N/A
- EPS Growth
- NXGL N/A
- TOI N/A
- EPS
- NXGL N/A
- TOI N/A
- Revenue
- NXGL $6,729,000.00
- TOI $378,933,000.00
- Revenue This Year
- NXGL $120.47
- TOI $29.17
- Revenue Next Year
- NXGL $38.19
- TOI $16.43
- P/E Ratio
- NXGL N/A
- TOI N/A
- Revenue Growth
- NXGL 90.57
- TOI 22.29
- 52 Week Low
- NXGL $1.84
- TOI $0.13
- 52 Week High
- NXGL $5.10
- TOI $2.45
- Technical
- Relative Strength Index (RSI)
- NXGL 38.55
- TOI 89.45
- Support Level
- NXGL $3.27
- TOI $0.25
- Resistance Level
- NXGL $3.93
- TOI $0.50
- Average True Range (ATR)
- NXGL 0.38
- TOI 0.09
- MACD
- NXGL -0.09
- TOI 0.04
- Stochastic Oscillator
- NXGL 11.02
- TOI 91.74
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.